Rémi Rosière
Rémi Rosière is a co-founder and chief scientific officer of InhaTarget Therapeutics, based in Brussels. He joined the company in June 2016 as a scientific researcher and entrepreneur, taking up his current role in August 2019. Since April 2021 he has also been a scientific advisor at CBX Medical.
He has been a scientific collaborator at the Université libre de Bruxelles since December 2019 and a lecturer at ULB HeLSci since 2018. Between June 2016 and November 2019 he worked at the Université libre de Bruxelles as a spin-off developer, and earlier as a PhD candidate and teaching assistant there. From October 2010 to September 2014 he held a FRIA grant as a doctoral student with F.R.S. - FNRS. He worked as a pharmacist at Pharmacie Nicolas from 2010 to 2015, having completed a pharmacy internship there.
Rosière holds a master's degree and a PhD in pharmaceutical sciences from the Université libre de Bruxelles, and followed entrepreneurship programmes at HEC Liège and the Solvay Brussels School of Economics and Management.
Career
- CBX MedicalScientific AdvisorApr 2021 – Present
InhaTarget TherapeuticsCo-Founder - Chief Scientific OfficerAug 2019 – Present
Université libre de Bruxelles#21factoryScientific CollaboratorDec 2019 – Present
- F.R.S. - FNRS#479factoryPh.D. Student-Grant FRIAOct 2010 – Sep 2014
- Pharmacie NicolasPharmacist (casual worker)Oct 2010 – Jun 2015
- Pharmacie NicolasPharmacistJul 2010 – Sep 2010
- Pharmacie NicolasPharmacy internshipJul 2009 – May 2010
- HEC Liège#32schoolFrom Research to Business (FR2B) - VentureLab, Entrepreneurship/Entrepreneurial Studies2017 - 2017
Solvay Brussels School of Economics and Management#6schoolCreation & Croissance, Entrepreneurship/Entrepreneurial Studies2017 - 2018
- Athénée Royal Adolphe SaxLatin-Sciences2000 - 2006
From public career histories · 19 entries